Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
KETOROLAC TROMETAMOL
LTT Pharma Limited
0.5 %w/v
Eye Drops Solution
2010-11-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Acular 0.5% w/v Eye Drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ketorolac trometamol 0.5% w/v Excipients: Benzalkonium chloride 0.01% w/v For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Eye drops, solution Product imported from the UK Clear, colourless to pale yellow aqueous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the prophylaxis and reduction of inflammation following cataract surgery. Acular is indicated in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Post-operative inflammation:_ One drop instilled into the eye three times daily starting 24 hours before surgery and continuing for three to four weeks. _Paediatric population_ There is no relevant use of ACULAR in the paediatric population in the indication: For the prophylaxis and reduction of inflammation following cataract surgery. _Method of administration_ Ocular use. Instil one drop of the solution into the inferior conjunctival sac of the eye to be treated, while pulling the lower eyelid gently downwards and looking upwards. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or any of the excipients The potential exists for cross-sensitivity to acetylsalicylic acid and other non-steroidal anti-inflammatory drugs.ACULAR ® is contra-indicated in individuals who have previously exhibited sensitivities to these drugs. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 09/12/2011_ _CRN 2099810_ _page number: 1_ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE It is recommended that ACULAR ® be used with caution in patients with known bleeding tendencies or who arereceiving other medications which may prolong ble Read the complete document